Innovent Biologics Inc. (IVBXF)

PNK: IVBXF · Real-Time Price · USD

5.97

0.00 (0.00%)

At close: Apr 29, 2025, 8:00 PM

Innovent Biologics Cash Flow Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-1.14B	-2.17B	-3.05B	-858.71M	-1.72B	-5.87B	-716.05M	-544.46M
Depreciation & Amortization	385.1M	319.42M	204.75M	85.63M	86.37M	64.06M	61.1M	54.59M
Stock-Based Compensation	574.2M	469.49M	501.57M	402.5M	153.07M	53.43M	29.3M	8.5M
Other Working Capital	475.07M	-29.63M	551.3M	-22.63M	151.22M	437.53M	64.24M	9.12M
Other Non-Cash Items	-70.47M	-847.15M	-49.55M	-5.34M	-28.16M	4.36B	99.17M	171.5M
Deferred Income Tax	n/a	n/a	50.38M	402.3M	-14.54M	-42.72M	-8.93M	-41.27M
Change in Working Capital	403.39M	309.91M	-90.28M	-334.06M	-141.26M	420.59M	43.15M	-11.87M
Operating Cash Flow	147.81M	-1.92B	-2.02B	-307.69M	-1.66B	-1.02B	-492.27M	-362.99M
Capital Expenditures	-1.38B	-1.38B	-1.85B	-771.78M	-365.87M	-312.74M	-90.97M	-58.44M
Cash Acquisitions	n/a	n/a	-630.14M	88.71M	70.53M	178.6M	4.75M	4.22M
Purchase of Investments	-9.41B	-10.33B	-10.34B	-11.64B	-4.85B	-786.48M	-1.12B	-817M
Sales Maturities Of Investments	9.24B	10.02B	10.12B	7.16B	2.58B	1.93B	850.97M	295.15M
Other Investing Acitivies	290.87M	252.4M	-4.08M	-17.22M	-5.1M	-147.78M	2.5M	4M
Investing Cash Flow	-998.66M	-1.44B	-2.7B	-5.18B	-2.57B	859.42M	-349.46M	-572.08M
Debt Repayment	418.5M	715.17M	1.21B	355.18M	33M	282M	10M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-86.36M	45.85M	-155.24M	-105.42M	-98.49M	4.15B	-24.84M	-26.6M
Financial Cash Flow	2.59B	2.89B	5B	4.91B	2.11B	4.43B	89.41M	1.64B
Net Cash Flow	1.73B	-343.24M	83.23M	-1.15B	-2.1B	4.34B	-779.23M	726.92M
Free Cash Flow	-1.24B	-3.3B	-3.87B	-1.08B	-2.03B	-1.33B	-583.24M	-421.44M